Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$67.3 - $69.67 $819,646 - $848,510
-12,179 Reduced 32.2%
25,648 $1.79 Million
Q2 2024

Jul 29, 2024

SELL
$66.47 - $69.65 $107,681 - $112,833
-1,620 Reduced 4.11%
37,827 $2.54 Million
Q1 2024

Apr 29, 2024

SELL
$56.67 - $69.36 $1.49 Million - $1.82 Million
-26,221 Reduced 39.93%
39,447 $2.72 Million
Q4 2023

Feb 07, 2024

BUY
$49.38 - $63.75 $2.66 Million - $3.44 Million
53,965 Added 461.12%
65,668 $4.09 Million
Q3 2023

Nov 02, 2023

SELL
$48.64 - $62.51 $18,191 - $23,378
-374 Reduced 3.1%
11,703 $656,000
Q2 2023

Aug 07, 2023

SELL
$47.99 - $60.21 $8,830 - $11,078
-184 Reduced 1.5%
12,077 $609,000
Q1 2023

May 09, 2023

SELL
$52.6 - $67.34 $4.62 Million - $5.91 Million
-87,772 Reduced 87.74%
12,261 $668,000
Q4 2022

Feb 09, 2023

BUY
$59.56 - $76.6 $4.77 Million - $6.14 Million
80,124 Added 402.45%
100,033 $6.26 Million
Q3 2022

Nov 09, 2022

SELL
$57.96 - $78.12 $7.1 Million - $9.57 Million
-122,495 Reduced 86.02%
19,909 $1.4 Million
Q2 2022

Aug 10, 2022

BUY
$39.5 - $64.42 $1.66 Million - $2.7 Million
41,908 Added 41.7%
142,404 $8.07 Million
Q1 2022

May 09, 2022

BUY
$43.74 - $62.76 $1.29 Million - $1.85 Million
29,415 Added 41.38%
100,496 $6.29 Million
Q4 2021

Feb 09, 2022

SELL
$50.01 - $73.35 $11.2 Million - $16.5 Million
-224,381 Reduced 75.94%
71,081 $3.98 Million
Q3 2021

Nov 09, 2021

SELL
$59.21 - $78.66 $6.31 Million - $8.38 Million
-106,509 Reduced 26.5%
295,462 $19.2 Million
Q2 2021

Aug 10, 2021

BUY
$51.39 - $66.9 $840,123 - $1.09 Million
16,348 Added 4.24%
401,971 $25.5 Million
Q1 2021

May 10, 2021

BUY
$49.14 - $59.89 $18.2 Million - $22.1 Million
369,795 Added 2336.33%
385,623 $23.1 Million
Q4 2020

Feb 08, 2021

BUY
$42.19 - $51.5 $172,936 - $211,098
4,099 Added 34.95%
15,828 $791,000
Q3 2020

Nov 06, 2020

BUY
$35.33 - $51.04 $158,349 - $228,761
4,482 Added 61.85%
11,729 $598,000
Q2 2020

Aug 05, 2020

BUY
$22.91 - $39.83 $166,028 - $288,648
7,247 New
7,247 $254,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.